Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
86 Leser
Artikel bewerten:
(0)

New Product Offerings Highlight Sysmex's Presence at 2014 AACC in Chicago

LINCOLNSHIRE, Ill., July 29, 2014 /PRNewswire/ --Sysmex America, Inc., a global leader in medical diagnostic testing equipment and information systems technology, will feature an exhibit booth during the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo in Chicago, July 27 through July 31, 2014.

Sysmex America, Inc. Logo.

"We are extremely excited to exhibit at AACC this year, because it's a tremendous opportunity to interact with our customers and continue the dialogue on how to best meet the needs of laboratories and their patients," said John Kershaw, President and Chief Executive Officer, Sysmex America, Inc. "It is also an opportunity to share the ways we continue to evolve with the industry - because the laboratory environment never stands still, and neither do we."

Moving Forward - New Product Offerings

At AACC, Sysmex America will introduce new product offerings that address the ever changing needs of the laboratory.

"We have much to offer the industry today, and not just in the future," said Kershaw. "It's a chance for us to demonstrate that we deliver, and we deliver in the present. In the past few years at AACC, there has been a progression of timely solutions we offer, and this year is no different in showing how we continue to move forward."

"We are not just offering instruments; we are offering peace of mind," continued Kershaw. "When a laboratory works with Sysmex, it is not just buying a dependable product; they are also getting a company that is fully committed to consistently adapt and evolve with them as their environment changes. Our focus goes beyond an analyzer; it is providing peace of mind now and for the future."

Offerings on display at the Sysmex Exhibit Booth include:

  • DI-60 TM Integrated Slide Processing System (Stand-alone Configuration) - Provides automation of manual WBC differential process in a stand-alone configuration, offering a cell image analyzer for any type of laboratory or budget.
  • XN-1000-100-R-01TM Automated Hematology Analyzer* - The latest addition to the XN-Series Automated Hematology Analyzers product line provides the same XN reliability and technology in a module that is designed for lower volume.(*For Investigational Use Only. Not for Use in Diagnostic Procedures.)
  • My SysmexTM Mobile Lab Assistant - An easy-to-use, mobile lab assistant that displays real time analyzer performance data. It enables laboratories to make informed decisions, share information and facilitate the ongoing education of staff. Quickly locate important performance information, consolidate reports, and create teachable moments, all available to the user by touching the My Sysmex screen.
  • CELLAVISION®DM9600 Cell Image Analysis System - This analyzer provides new ways of handling the manual differential traditionally performed on a microscope.

For more detailed information on these products, please contact Scott Kirn - Sysmex Media Relations for a product backgrounder.

Sysmex at AACC

During the AACC meeting, Sysmex will host a comprehensive program of educational presentations at the Sysmex booth #2021. For more information, visit: http://sysmexconnect.com.

Sysmex associates from around the world will be available to speak with clinical laboratory professionals about the Sysmex integrated automation for hematology, middleware, cell image analysis and customer services at the Sysmex booth.

AACC is the world's largest gathering of clinical laboratory professionals including laboratory management, researchers, GPOs and product development specialists and hosts the largest exposition of clinical laboratory products and services in the world.-‹

About Sysmex America, Inc.

Sysmex America, Inc., in Lincolnshire, Illinois, the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a trusted world leader in clinical laboratory systemization and solutions that optimize the clinical utility, operational efficiency and financial performance of the lab. Sysmex America distributes and supports a diversified portfolio of best-in-class automated in vitro diagnostic hematology, coagulation and urinalysis analyzers, reagents and information systems for laboratories and healthcare facilities throughout the Western Hemisphere. The Company's unwavering commitment to clinical excellence and technological innovation is reflected in the Sysmex brand and its distinguished heritage of unsurpassed reliability. Sysmex is reshaping the healthcare of tomorrow at the clinical laboratory level by transcending the boundaries of diagnostic science and serving as the pulse of reliable, accountable care. For more information about Sysmex, please visit www.sysmex.com/us

Logo- http://photos.prnewswire.com/prnh/20130612/CG30721LOGO-b

SOURCE Sysmex America, Inc.

© 2014 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.